Drug–Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation

Ling Li,Jannah Baker,Renee Quirk,Danielle Deidun,Maria Moran,Ahmed Abo Salem,Nanda Aryal,Bethany A. Van Dort,Wu Yi Zheng,Andrew Hargreaves,Paula Doherty,Sarah N. Hilmer,Richard O. Day,Johanna I. Westbrook,Melissa T. Baysari
DOI: https://doi.org/10.1007/s40264-024-01412-w
2024-03-14
Drug Safety
Abstract:Drug–drug interactions (DDIs) have potential to cause patient harm, including lowering therapeutic efficacy. This study aimed to (i) determine the prevalence of potential DDIs (pDDIs); clinically relevant DDIs (cDDIs), that is, DDIs that could lead to patient harm, taking into account a patient's individual clinical profile, drug effects and severity of potential harmful outcome; and subsequent actual harm among hospitalized patients and (ii) examine the impact of transitioning from paper-based medication charts to electronic medication management (eMM) on DDIs and patient harms.
pharmacology & pharmacy,public, environmental & occupational health,toxicology
What problem does this paper attempt to address?